<DOC>
	<DOCNO>NCT02279953</DOCNO>
	<brief_summary>To assess efficacy vortioxetine ( 10 20 mg/day ) adjunctive treatment stable selective serotonin reuptake inhibitor ( SSRI ) dose versus stable SSRI monotherapy cognitive performance ( focus aspect concern speed processing , executive function attention ) patient partial full remission Major Depressive Episode ( MDE ) .</brief_summary>
	<brief_title>Efficacy Vortioxetine Cognitive Dysfunction Patients With Partial Full Remission Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Vortioxetine</mesh_term>
	<criteria>The patient achieve either partial ( symptoms MDE present full criterion meet ) full remission major depressive disorder ( MDD ) , diagnose accord DSMIVTR™ . The patient HAMD17 total score ≤10 . The patient receive SSRI monotherapy MDE patient currently full partial remission ≥12 week license dos stable dose ≥8 week prior Screening Visit . The patient ≥50 % response current SSRI treatment ( Antidepressant Treatment Response Questionnaire [ ATRQ ] ) . The patient PDQD total score &gt; 25 . The patient man woman , age ≥18 ≤65 year . The patient score ≥70 DSST ( number correct symbol ) Baseline Visit . The patient , opinion investigator , able complete neuropsychological test validly Baseline Visit . The patient physical , cognitive , language impairment severity adversely affect validity data derive neuropsychological test . The patient diagnose read disability ( dyslexia ) . The patient history lack response previous adequate treatment vortioxetine . The patient current psychiatric disorder Axis I disorder ( accord DSMIVTR™ criterion ) MDD , assess use Mini International Neuropsychiatric Interview ( MINI ) . The patient current diagnosis dysthymic disorder within 3 month precede onset depressive episode patient currently full partial remission ( DSMIVTR™ criterion ) . The patient borderline , schizotypal , schizoid , paranoid , histrionic , antisocial personality disorder ( axis II ) comorbid primary diagnosis ( DSMIVTR™ criterion ) . The patient suffers personality disorder , mental retardation , pervasive development disorder , attentiondeficit/hyperactivity disorder , organic mental disorder , mental disorder due general medical condition ( DSMIVTR™ criterion ) . The patient current diagnosis history manic hypomanic episode , schizophrenia psychotic disorder , include major depression psychotic feature ( DSMIVTR™ criterion ) . Other protocoldefined inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>